Table 2 Serious adverse events regardless of relationship to study drug
Preferred term | ||
|---|---|---|
Pt | Before ESA | After ESA |
1 | Cholesteatoma | |
2 | Respiratory tract infection | General physical deteriorationa |
Respiratory tract infectiona | ||
Renal failure, acute | ||
5 | NA | Hip fracture |
Septic shock | ||
Pneumonitis | ||
Depressed consciousness | ||
6 | Pulmonary arterial hypertension | Ascites |
Anemiab | Encephalopathy | |
Varices esophageal | Enterococcal sepsis | |
Upper gastrointestinal hemorrhage | ||
8 | NA | Herpes zoster |
Pulmonary embolism | ||
Cardiac failure | ||
9 | NA | Abdominal pain |
Urinary tract infection | ||
Anemiaa,b | ||
Radius fracture | ||
Lung infiltration | ||
Pneumonia | ||
Sepsis | ||
Renal failure | ||
Supraventricular tachycardia | ||
Hepatic failure | ||
Tachypnea | ||
Hyperuricemia | ||
Lumbar vertebral fracture | ||
Thoracic vertebral fracture | ||
Respiratory failure | ||
10 | NA | Traumatic fracture |
13 | NA | Gastroenteritis |